Publication Date
12-1-2022
Journal
Cancer Prevention Research
Abstract
Our results show that everolimus delays mammary tumor formation in multiple mouse models, suggesting that mTOR inhibitors will be useful for the prevention of ER-negative and triple-negative breast cancer in humans. See related Spotlight, p. 787.
Keywords
Humans, Mice, Animals, Female, Receptors, Estrogen, TOR Serine-Threonine Kinases, Mammary Neoplasms, Animal, Everolimus, Breast Neoplasms
Included in
Bioinformatics Commons, Biomedical Informatics Commons, Medical Sciences Commons, Obstetrics and Gynecology Commons, Oncology Commons, Women's Health Commons
Comments
Supplementary Materials
PMID: 35981902